Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM

INTRODUCTION: Clinical course and treatment response may vary according to race/ethnicity in multiple sclerosis (MS) patients. Delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF) demonstrated significant efficacy and a favorable benefit–risk profile in relapsing-remitting MS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Ther
Autors principals: Fox, Robert J., Gold, Ralf, Phillips, J. Theodore, Okwuokenye, Macaulay, Zhang, Annie, Marantz, Jing L.
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700899/
https://ncbi.nlm.nih.gov/pubmed/28770420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-017-0077-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars